Oral Rehydration Solution Market Report 2026

The oral rehydration solution market size has grown strongly in recent years. It will grow from $4.42 billion in 2025 to $4.83 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to high prevalence of diarrheal diseases, global public health programs, widespread use of ors in low-resource settings, expansion of pharmacy distribution, increased child healthcare initiatives.

The oral rehydration solution market size is expected to see strong growth in the next few years. It will grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to growth in preventive healthcare awareness, increasing climate-related dehydration risks, rising pediatric population in emerging markets, expansion of rural healthcare access, innovation in ors formulations. Major trends in the forecast period include increasing demand for ready-to-use ors products, growing adoption of pediatric ors formulations, rising focus on community-level dehydration management, expansion of flavored and enhanced ors variants, increasing distribution through e-commerce channels.

The rising incidence of diarrheal diseases is expected to drive growth in the oral rehydration solution market in the coming years. Diarrheal disease is a condition characterized by frequent, loose, or watery bowel movements, often accompanied by abdominal cramps and dehydration. Its increase is largely due to poor sanitation, as inadequate waste disposal and lack of clean water facilitate the spread of pathogens that cause gastrointestinal infections. Oral rehydration solutions help treat dehydration caused by diarrheal diseases by replenishing lost fluids and electrolytes, preventing severe complications and death. For example, in March 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that diarrhea accounts for approximately 443,832 deaths among children under the age of five, with an additional 50,851 deaths among children aged 5 to 9 each year. Consequently, the rising incidence of diarrheal diseases is fueling the oral rehydration solution market.

Leading companies in the oral rehydration solution market are focusing on technological innovations, such as precise osmolarity, to enhance hydration effectiveness, maintain optimal electrolyte balance, and improve treatment outcomes for dehydration-related conditions. Accurate osmolarity ensures the correct concentration of solutes, such as salts and sugars, in a solution, aligning with the body’s natural fluid balance. For example, in January 2025, Kenvue Inc., a U.S.-based consumer health company, launched WHO ORS, a ready-to-drink oral rehydration solution designed to support effective treatment of diarrhea-induced dehydration. This innovative solution features optimized electrolytes and balanced osmolarity, promoting better hydration, accelerating recovery, and enhancing treatment outcomes. WHO ORS provides effective hydration for diarrhea-induced dehydration with balanced electrolytes and osmolarity to support faster recovery.

In August 2023, Ennismore, a UK-based lifestyle hospitality company, partnered with Dripdrop to provide convenient hydration solutions at select properties. Through this collaboration, Ennismore and Dripdrop aim to enhance guest wellness, deliver effective hydration, and elevate the overall guest experience with innovative wellness offerings. Dripdrop is a U.S.-based hydration company specializing in oral rehydration solutions for rapid recovery from dehydration.

Major companies operating in the oral rehydration solution market are Abbott Laboratories, Otsuka Pharmaceutical Co. Ltd., Intas Pharmaceuticals Ltd., Zydus Cadila Healthcare Ltd., Mankind Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Alkem Laboratories Limited, Ajanta Pharma Limited, Shreya Life Sciences Pvt. Ltd., Renata Limited, FDC Limited, ACME Laboratories Ltd., Wallace Pharmaceuticals Pvt. Ltd., Halewood Laboratories Pvt. Ltd., Cian Healthcare Limited, Ziska Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd.

North America was the largest region in the oral rehydration solution market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral rehydration solution market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oral rehydration solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the oral rehydration solution market by increasing the cost of imported packaging materials and key raw ingredients used in ORS production. These impacts are most visible in large scale ORS distribution programs across Asia Pacific and Africa, where affordability and supply continuity are critical. Rising tariff related expenses have marginally increased product costs and logistics spending for public health initiatives. This has influenced procurement planning and budgeting for government and aid funded programs. Positively, tariffs have promoted local manufacturing, regional sourcing of ORS products, and stronger long term supply resilience.

The oral rehydration solution market research report is one of a series of new reports that provides oral rehydration solution market statistics, including oral rehydration solution industry global market size, regional shares, competitors with a oral rehydration solution market share, detailed oral rehydration solution market segments, market trends and opportunities, and any further data you may need to thrive in the oral rehydration solution industry. This oral rehydration solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Oral rehydration solution (ORS) is a simple and effective treatment used to prevent and manage dehydration caused by diarrhea. It contains a precise balance of salts and sugars to help restore the body’s fluids. ORS is commonly used for conditions such as gastroenteritis, cholera, and other illnesses that result in fluid loss. Its oral administration makes it accessible even in low-resource settings.

The main types of oral rehydration solutions include ready-to-use ORS packets and ORS powder for reconstitution. Ready-to-use ORS packets are pre-measured, sealed sachets containing the exact mix of salts and sugars, which are dissolved in water to treat dehydration. ORS is indicated for diarrhea, gastroenteritis, and other related conditions. Packaging options include pouches, bottles, bulk packages, single-serve sachets, and cans. Distribution channels include online stores, pharmacies, supermarkets or hypermarkets, specialty stores, and other outlets. ORS caters to a wide range of end-users, including children, adults, and the elderly.

The oral rehydration solution market consists of sales of sodium bicarbonate-based ORS, herbal ORS, and electrolyte-based ORS. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.